If approved, it will be offered to people who are living with obesity
Pre-restart assessment should include: Review of the reason for discontinuation and whether it has been adequately addressed Current weight and glycemic status (if diabetic) Assessment of gastrointestinal symptoms and any contraindications Medication reconciliation to identify potential drug interactions For patients taking insulin or sulfonylureas, consider dose reductions to prevent hypoglycemia For women of childbearing potential using oral contraceptives, recommend backup contraception for 4 weeks after restarting and after each dose increase Discussion of realistic expectations and commitment to continued treatment Patient counseling is essential
Analytical sensitivity was determined by analyzing the Optiquant HCV RNA Quantification Panel (Acrometrix, Benicia, CA, USA)
Every consultation begins with listening
For lean-mass/sleep/recovery goals, CJC-1295 is the more common pick
However, the exact timing should be determined in consultation with your doctor